Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 140Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 101Lymphoma, Non-Hodgkin 87Multiple Myeloma 83Hodgkin Disease 75Leukemia, Lymphocytic, Chronic, B-Cell 70Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Myeloproliferative Disorders 57Lymphoma, Large B-Cell, Diffuse 57Neoplasms, Plasma Cell 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Follicular 52Lymphoma, Mantle-Cell 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, Large-Cell, Immunoblastic 44Blast Crisis 44Anemia, Refractory, with Excess of Blasts 43Primary Myelofibrosis 40Recurrence 37Hematologic Neoplasms 35Graft vs Host Disease 35Myelodysplastic-Myeloproliferative Diseases 34Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32

Interventions

fludarabine phosphate 4fludarabine 4Cyclophosphamide 4Thiotepa 3Melphalan 3Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Fentanyl 2Busulfan 2Alemtuzumab 2AP 1903 reagent 2voxelotor 1thymoglobulin 1maltodextrin 1Rituximab 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Medical Marijuana 1Interviews as Topic 1Imagery, Psychotherapy 1Holistic Health 1Glutamine 1Erythrocyte Count 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Sickle Cell × Busulfan × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡